Brief: Rapport Reports Positive Focal Onset Seizures Trial Results
08/09/2025 11:28
Sept 8 (Reuters) - Rapport Therapeutics Inc RAPP.O: RAPPORT ANNOUNCES POSITIVE TOPLINE RESULTS FROM PHASE 2A CLINICAL TRIAL OF RAP-219 IN PATIENTS WITH FOCAL ONSET SEIZURES RAPPORT THERAPEUTICS INC - TRIAL MEETS PRIMARY ENDPOINTS, RAP-219 WELL TOLERATED RAPPORT THERAPEUTICS INC - PATIENTS ACHIEVE 77.8% SEIZURE REDUCTION, 24% SEIZURE FREEDOM RAPPORT THERAPEUTICS INC - RAP-219 WELL-TOLERATED WITH MILD ADVERSE EVENTS RAPPORT THERAPEUTICS INC - PLANS END-OF-PHASE 2 MEETING WITH FDA IN Q4 2025 Source text: ID:nGNX9vKCj6 Further company coverage: RAPP.O ((Reuters.Briefs@thomsonreuters.com;))